Brief: Biotech chief business development officer resigns
Feb 28 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* REG-PCI BIOTECH: RESIGNATION OF CHIEF BUSINESS DEVELOPMENT
OFFICER
* CHIEF BUSINESS DEVELOPMENT OFFICER (CBDO), GAËL L’HÉVÉDER
HAS
RESIGNED AND WILL LEAVE PCI BIOTECH AS PER END OF MARCH 2019 TO
PURSUE OTHER CAREER OPPORTUNITIES
Source text for Eikon: ID:nGNE5w7Q95
Further company coverage: PCIB.OL
(Reporting By Oslo Newsroom)
((balazs.koranyi@thomsonreuters.com;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process